These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 33524871)
1. SH3GL3 acts as a novel tumor suppressor in glioblastoma tumorigenesis by inhibiting STAT3 signaling. Nie Z; Cai S; Wei Z; Li Y; Bian L; Wang C; Wang X; Wang C Biochem Biophys Res Commun; 2021 Mar; 544():73-80. PubMed ID: 33524871 [TBL] [Abstract][Full Text] [Related]
2. SH3BGRL3, transcribed by STAT3, facilitates glioblastoma tumorigenesis by activating STAT3 signaling. Nie Z; Cheng D; Pan C; Wei Z; Wang C; Wang C Biochem Biophys Res Commun; 2021 Jun; 556():114-120. PubMed ID: 33839406 [TBL] [Abstract][Full Text] [Related]
3. TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3. Zhang C; Mukherjee S; Tucker-Burden C; Ross JL; Chau MJ; Kong J; Brat DJ Mol Oncol; 2017 Mar; 11(3):280-294. PubMed ID: 28100038 [TBL] [Abstract][Full Text] [Related]
4. SH3BGRL2 functions as a crucial tumor suppressor in glioblastoma tumorigenesis. Nie Z; Cai S; Wei Z; Li Y; Bian L; Wang C; Wang C Biochem Biophys Res Commun; 2021 Apr; 547():148-154. PubMed ID: 33610914 [TBL] [Abstract][Full Text] [Related]
5. An Integrated Bioinformatics Study of a Novel Niclosamide Derivative, NSC765689, a Potential Mokgautsi N; Wen YT; Lawal B; Khedkar H; Sumitra MR; Wu ATH; Huang HS Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671112 [TBL] [Abstract][Full Text] [Related]
6. Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells. Shi Y; Zhou W; Cheng L; Chen C; Huang Z; Fang X; Wu Q; He Z; Xu S; Lathia JD; Ping Y; Rich JN; Bian XW; Bao S Cell Death Differ; 2017 Jan; 24(1):167-180. PubMed ID: 27740621 [TBL] [Abstract][Full Text] [Related]
7. BIS-mediated STAT3 stabilization regulates glioblastoma stem cell-like phenotypes. Im CN; Yun HH; Song B; Youn DY; Cui MN; Kim HS; Park GS; Lee JH Oncotarget; 2016 Jun; 7(23):35056-70. PubMed ID: 27145367 [TBL] [Abstract][Full Text] [Related]
8. Loss of SH3GL2 promotes the migration and invasion behaviours of glioblastoma cells through activating the STAT3/MMP2 signalling. Zhu Y; Zhang X; Wang L; Ji Z; Xie M; Zhou X; Liu Z; Shi H; Yu R J Cell Mol Med; 2017 Nov; 21(11):2685-2694. PubMed ID: 28470949 [TBL] [Abstract][Full Text] [Related]
9. RBPJ contributes to the malignancy of glioblastoma and induction of proneural-mesenchymal transition via IL-6-STAT3 pathway. Zhang G; Tanaka S; Jiapaer S; Sabit H; Tamai S; Kinoshita M; Nakada M Cancer Sci; 2020 Nov; 111(11):4166-4176. PubMed ID: 32885530 [TBL] [Abstract][Full Text] [Related]
10. High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma. Jeong HY; Kim HJ; Kim CE; Lee S; Choi MC; Kim SH Int J Neurosci; 2021 Jan; 131(1):7-14. PubMed ID: 32075484 [No Abstract] [Full Text] [Related]
11. The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells. Kim SH; Kim EJ; Hitomi M; Oh SY; Jin X; Jeon HM; Beck S; Jin X; Kim JK; Park CG; Chang SY; Yin J; Kim T; Jeon YJ; Song J; Lim YC; Lathia JD; Nakano I; Kim H Cell Death Differ; 2015 Sep; 22(9):1517-25. PubMed ID: 25721045 [TBL] [Abstract][Full Text] [Related]
12. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3. Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1. Bier A; Giladi N; Kronfeld N; Lee HK; Cazacu S; Finniss S; Xiang C; Poisson L; deCarvalho AC; Slavin S; Jacoby E; Yalon M; Toren A; Mikkelsen T; Brodie C Oncotarget; 2013 May; 4(5):665-76. PubMed ID: 23714687 [TBL] [Abstract][Full Text] [Related]
15. Neurotensin signaling regulates stem-like traits of glioblastoma stem cells through activation of IL-8/CXCR1/STAT3 pathway. Zhou J; Yi L; Ouyang Q; Xu L; Cui H; Xu M Cell Signal; 2014 Dec; 26(12):2896-902. PubMed ID: 25200966 [TBL] [Abstract][Full Text] [Related]
16. Interaction of NF-κB and FOSL1 drives glioma stemness. Ramar V; Guo S; Hudson B; Khedri A; Guo AA; Li J; Liu M Cell Mol Life Sci; 2024 Jun; 81(1):255. PubMed ID: 38856747 [TBL] [Abstract][Full Text] [Related]
17. SH3GL3 functions as a potent tumor suppressor in lung cancer in a SH3 domain dependent manner. Lin Z; Liu Z; Tan X; Li C Biochem Biophys Res Commun; 2021 Jan; 534():787-794. PubMed ID: 33168185 [TBL] [Abstract][Full Text] [Related]
18. Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations. Garner JM; Ellison DW; Finkelstein D; Ganguly D; Du Z; Sims M; Yang CH; Interiano RB; Davidoff AM; Pfeffer LM PLoS One; 2015; 10(5):e0125838. PubMed ID: 25955030 [TBL] [Abstract][Full Text] [Related]
19. RRAD promotes EGFR-mediated STAT3 activation and induces temozolomide resistance of malignant glioblastoma. Yeom SY; Nam DH; Park C Mol Cancer Ther; 2014 Dec; 13(12):3049-61. PubMed ID: 25313011 [TBL] [Abstract][Full Text] [Related]
20. The interference of Notch1 target Hes1 affects cell growth, differentiation and invasiveness of glioblastoma stem cells through modulation of multiple oncogenic targets. Cenciarelli C; Marei HE; Zonfrillo M; Casalbore P; Felsani A; Giannetti S; Trevisi G; Althani A; Mangiola A Oncotarget; 2017 Mar; 8(11):17873-17886. PubMed ID: 28157712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]